Download PDF
Thromb Haemost 2010; 104(02): 415-417
DOI: 10.1160/TH10-02-0114
Letters to the Editor
Schattauer GmbH

Functional characterisation of plasma fibrin clots in Polish carriers of fibrinogen γArg275His mutation (fibrinogen Zabrze)

Anetta Undas
1   Institute of Cardiology, Jagiellonian University School of Medicine, Krakow, Poland
4   John Paul II Hospital, Krakow, Poland
,
Maciej Pastuszczak
2   Department of Pathophysiology, Jagiellonian University School of Medicine, Krakow, Poland
,
Teresa Iwaniec
3   Department of Internal Medicine, Jagiellonian University School of Medicine, Krakow, Poland
,
Krystyna Kapelak
4   John Paul II Hospital, Krakow, Poland
,
Marguerite Neerman-Arbez
5   Division of Angiology and Haemostasis, University Hospital, Geneva, Switzerland
6   Department of Genetic Medicine and Development, University Medical Centre, Geneva, Switzerland
› Author Affiliations Financial support: This work has been supported by a grant of the Jagiellonian University School of Medicine (K/ZDS/000565; to A. U.).
Further Information

Publication History

Received: 13 February 2010

Accepted after major revision: 25 May 2010

Publication Date:
24 November 2017 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Hanss M, Biot F. A database for human fibrinogen variants. Ann NY Acad Sci 2001; 936: 89-90 http://www.geht.org/databaseang/fibrinogen (September 2008, release 28).
    PubMedGoogle Scholar
  • 2 Borrel M, Gari M, Coll I. et al. Abnormal polymerization and normal binding of plasminogen and t-PA in three new dysfibrinogenaemias: Barcelona III and IV (γArg275→His) and Villajoyosa (γArg275→Cys). Blood Coagul Fibrinolysis 1995; 06: 198-206.
    CrossrefPubMedGoogle Scholar
  • 3 Reber P, Furlan M, Henschen A. et al. Three abnormal fibrinogen variants with the same amino acid substitution (γ275 Arg→His): Fibrinogens Bergamo II, Essen and Perugia. Thromb Haemost 1986; 56: 401-406.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Yoshida N, Imaoka S, Hirata H. et al. Heterozygous abnormal fibrinogen Osaka III with the replacement of γ arginine-275 by histidine has an apparently higher molecular weight γ-chain variant. Thromb Haemost 1992; 68: 534-538.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Kotlin R, Reicheltova Z, Sobotkova A. et al. Three cases of abnormal fibrinogens: Sumperk (Bβ His67Leu), Unicov (Bβ Gly41Ser), and Brno (γArg275His). Thromb Haemost 2008; 100: 1199-1200.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Soria J, Soria C, Samma M. et al. Fibrinogen Haifa: Fibrinogen variant with absence of protective effect of calcium on plasmin degradation of gamma chains. Thromb Haemost 1987; 57: 310-313.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Yamazumi K, Terukina S, Onohara S. et al. Normal plasmic cleavage of the γ-chain variant of “Fibrinogen Saga„ with an Arg-275 to His substitution. Thromb Haemost 1988; 60: 476-480.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Guglielmone HA, Minoldo S, Jarchum GD. Fibrinogen Cordoba I: A γArg275His substitution associated with defective polymerization. Thromb Res 2007; 121: 429-430.
    CrossrefPubMedGoogle Scholar
  • 9 Cote HCF, Lord ST, Pratt KP. γ-chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the γ chain of human fibrinogen. Blood 1998; 92: 2195-2212.
    PubMedGoogle Scholar
  • 10 Hirota-Kawadobora M, Terasawa F, Suzuki T. et al. Comparison of thrombin-catalyzed fibrin polymerization and factor XIIIa-catalyzed cross-linking of fibrin among three recombinant variant fibrinogens, gamma275C, gamma275H, and gamma275A. J Thromb Haemost 2004; 02: 1359-1367.
    CrossrefPubMedGoogle Scholar
  • 11 Robert-Ebadi H, Le Querrec A, de Moerloose P. et al. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis. Blood Coagul Fibrinolysis 2008; 19: 697-699.
    CrossrefPubMedGoogle Scholar
  • 12 Undas A, Zawilska K, Ciesla-Dul M. et al. Altered fibrin clot structure/function in patients with idiopathic venous thrombembolism and in their relatives. Blood 2009; 114: 4272-4278.
    CrossrefPubMedGoogle Scholar
  • 13 Carter AM, Cymbalista CM, Spector TD. et al. Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Arterioscler Thromb Vasc Biol 2007; 27: 2783-2789.
    CrossrefPubMedGoogle Scholar
  • 14 Carr ME. Fibrin formed in plasma us composed of fibers more massive than those formed from purified fibrinogen. Thromb Haemost 1998; 59: 535-539.
    Article in Thieme ConnectPubMedGoogle Scholar